title: Multicenter analysis of platelet transfusion usage among neonates on extracorporeal membrane oxygenation.
abstract: OBJECTIVE
  Multiple platelet transfusions are invariably given to neonates on extracorporeal membrane oxygenation (ECMO), and no alternative to repeated transfusions exists. Before any alternatives, such as administration of thrombopoietic stimulators, could be contemplated, data regarding the number of platelet transfusions received by neonatal ECMO patients is needed, and the mechanisms that cause the thrombocytopenia of these patients must be better defined. As a step toward determining this, we analyzed the use of platelet transfusions in this group of neonates. We conducted a historic cohort study of neonates who were treated with ECMO to determine the number of platelet units received as a function of 1) days on ECMO, 2) medical diagnosis for which ECMO was instituted, and 3) type of ECMO used (venovenous [VV] vs venoarterial [VA]).
  
  
  METHODS
  We reviewed the hospital records of all neonates who were admitted to the neonatal intensive care units at Shands Children's Hospital, Arnold Palmer Hospital for Children and Women, and Tampa General Hospital and treated with ECMO between January 1, 1995, and June 30, 2000. Data were expressed as the number of platelet transfusions versus number of days on ECMO, diagnosis for which ECMO was instituted, and type of ECMO used.
  
  
  RESULTS
  Of the 234 ECMO patients, 81 were placed on VV, 138 were placed on VA, and 15 were converted from VV to VA. The average number of platelet transfusions received per day was 1.3 and varied by diagnosis and by type of ECMO. Neonates with meconium aspiration and sepsis required more platelet transfusions per day than neonates with other conditions. Infants who were converted from VV to VA required more transfusions per day (mean: 1.57) than did patients on VA (1.47) or VV (1.06).
  
  
  CONCLUSIONS
  Platelet transfusions among neonates on ECMO are dependent of their medical diagnosis; they average 1.3 transfusions per day and are higher on VA than VV ECMO.
authors.affiliation: Department of Pediatrics, University of Florida, Gainesville, Florida, USA.
authors.forename: Srinivas C
authors.initials: SC
authors.lastname: Chevuru
authors.forename: Martha C
authors.initials: MC
authors.lastname: Sola
authors.forename: Douglas W
authors.initials: DW
authors.lastname: Theriaque
authors.forename: Alan D
authors.initials: AD
authors.lastname: Hutson
authors.forename: Wilfred C W
authors.initials: WC
authors.lastname: Leung
authors.forename: Jose A
authors.initials: JA
authors.lastname: Perez
authors.forename: Robert M
authors.initials: RM
authors.lastname: Nelson
authors.forename: David W
authors.initials: DW
authors.lastname: Kays
authors.forename: Robert D
authors.initials: RD
authors.lastname: Christensen
mesh_terms: D001724:Birth Weight; D015199:Extracorporeal Membrane Oxygenation / Q000379:methods*; D005865:Gestational Age; D006548:Hernia, Diaphragmatic / Q000097:blood / Q000628:therapy; D065630:Hernias, Diaphragmatic, Congenital; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000097:blood / Q000628:therapy*; D007363:Intensive Care Units, Neonatal / Q000706:statistics & numerical data; D008471:Meconium Aspiration Syndrome / Q000097:blood / Q000628:therapy; D010547:Persistent Fetal Circulation Syndrome / Q000628:therapy; D010976:Platelet Count; D017713:Platelet Transfusion / Q000379:methods / Q000706:statistics & numerical data*; D012127:Respiratory Distress Syndrome, Newborn / Q000097:blood / Q000628:therapy; D018805:Sepsis / Q000097:blood / Q000628:therapy; D016896:Treatment Outcome